Literature DB >> 10491298

In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.

S Oh1, Y H Song, U J Kim, J Yim, T K Kim.   

Abstract

Induction of the catalytic subunit of human telomerase, hTERT, plays a critical role in the activation of telomerase during tumorigenesis. Here, we isolate the hTERT gene promoter and define the functional promoter region, which is inactive in normal cells but active in tumor cells. Myc directly interacts with the hTERT promoter and activates its transcription both in vivo and in vitro. Activation or repression of Myc can alter hTERT promoter activities in normal or tumor cells. Furthermore, we detect high levels of Myc protein in tumor cells compared with normal cells. The ability of Myc to modulate the activity of the hTERT promoter and, hence, the telomerase enzyme may contribute to its ability to promote tumor formation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491298     DOI: 10.1006/bbrc.1999.1366

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

1.  Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells.

Authors:  Jaejoon Won; Seungwoo Chang; Sangtaek Oh; Tae Kook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

2.  The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.

Authors:  Rosalind M Glasspool; Sharon Burns; Stacey F Hoare; Catharina Svensson; W Nicol Keith
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

3.  Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter.

Authors:  M Tzukerman; C Shachaf; Y Ravel; I Braunstein; O Cohen-Barak; M Yalon-Hacohen; K L Skorecki
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

4.  PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.

Authors:  Hong-bin Wang; Xing-wei Wang; Gang Zhou; Wei-qiang Wang; Yong-gang Sun; Shi-ming Yang; Dian-chun Fang
Journal:  J Gastrointest Surg       Date:  2010-06-11       Impact factor: 3.452

5.  p16(INK4a) -mediated suppression of telomerase in normal and malignant human breast cells.

Authors:  Alexey V Bazarov; Marjolein Van Sluis; William C Hines; Ekaterina Bassett; Alain Beliveau; Eric Campeau; Rituparna Mukhopadhyay; Won Jae Lee; Sonya Melodyev; Yuri Zaslavsky; Leonard Lee; Francis Rodier; Agustin Chicas; Scott W Lowe; Jean Benhattar; Bing Ren; Judith Campisi; Paul Yaswen
Journal:  Aging Cell       Date:  2010-07-14       Impact factor: 9.304

Review 6.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 7.  Papillomavirus E6 proteins.

Authors:  Heather L Howie; Rachel A Katzenellenbogen; Denise A Galloway
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

Review 8.  Adenoviral vectors for prodrug activation-based gene therapy for cancer.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

9.  Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  Telomere length on chromosome 17q shortens more than global telomere length in the development of breast cancer.

Authors:  Fariborz Rashid-Kolvear; Melania Pintilie; Susan J Done
Journal:  Neoplasia       Date:  2007-04       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.